Revvity Inc
RVTY96.200USD
-0.060-0.06%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
10.97BMarket Cap
48.35P/E TTM
More Details of Revvity Inc Company
Revvity, Inc. is a provider of health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. The Company has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards the life sciences market. The segment offers instruments, reagents, software, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools, and applications focused on clinically oriented customers, within the reproductive health, immunodiagnostics, and applied genomics markets. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families.
Revvity Inc Info
Ticker SymbolRVTY
Company nameRevvity Inc
IPO dateAug 12, 2101
CEOSingh (Prahlad R)
Number of employees11000
Security typeOrdinary Share
Fiscal year-endAug 12
Address77 4Th Avenue
CityWALTHAM
Stock exchangeNASDAQ OMX NASDAQ Basic NYSE
CountryUnited States of America
Postal code02451
Phone17816636900
Websitehttps://www.revvity.com/
Ticker SymbolRVTY
IPO dateAug 12, 2101
CEOSingh (Prahlad R)
Company Executives of Revvity Inc
Name
Name/Position
Position
Shareholding
Change
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
96.84K
-8.87%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
45.44K
+6.67%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+12.84%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
26.01K
+10.22%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
22.80K
-2.39%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
14.29K
+61.74%
Ms. Pascale Witz
Ms. Pascale Witz
Independent Director
Independent Director
13.71K
+21.36%
Mr. Tajinder S. Vohra
Mr. Tajinder S. Vohra
Senior Vice President - Global Operations
Senior Vice President - Global Operations
10.44K
-53.85%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Independent Director
Independent Director
5.09K
+90.13%
Dr. Sophie V. Vandebroek, Ph.D.
Dr. Sophie V. Vandebroek, Ph.D.
Independent Director
Independent Director
5.09K
+90.13%
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Prahlad R. Singh, Ph.D.
Dr. Prahlad R. Singh, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
96.84K
-8.87%
Mr. Alexandros P. (Alexis) Michas
Mr. Alexandros P. (Alexis) Michas
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
45.44K
+6.67%
Mr. Joel S. Goldberg
Mr. Joel S. Goldberg
Senior Vice President - Administration, General Counsel, Secretary
Senior Vice President - Administration, General Counsel, Secretary
37.69K
+12.84%
Dr. Peter Barrett, Ph.D.
Dr. Peter Barrett, Ph.D.
Independent Director
Independent Director
26.01K
+10.22%
Mr. Maxwell Krakowiak
Mr. Maxwell Krakowiak
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
22.80K
-2.39%
Ms. Miriame Victor
Ms. Miriame Victor
Chief Commercial Officer, Senior Vice President
Chief Commercial Officer, Senior Vice President
14.29K
+61.74%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Product
610.70M
84.79%
Service
109.58M
15.21%
By RegionUSD
Name
Revenue
Proportion
Americas
323.58M
44.92%
Europe
203.63M
28.27%
Asia
193.07M
26.80%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Product
610.70M
84.79%
Service
109.58M
15.21%
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
T. Rowe Price Investment Management, Inc.
19.85%
The Vanguard Group, Inc.
11.88%
EdgePoint Investment Group Inc.
7.56%
T. Rowe Price Associates, Inc.
7.05%
Janus Henderson Investors
6.73%
Other
46.93%
Shareholders
Shareholders
Proportion
T. Rowe Price Investment Management, Inc.
19.85%
The Vanguard Group, Inc.
11.88%
EdgePoint Investment Group Inc.
7.56%
T. Rowe Price Associates, Inc.
7.05%
Janus Henderson Investors
6.73%
Other
46.93%
Shareholder Types
Shareholders
Proportion
Investment Advisor
70.04%
Investment Advisor/Hedge Fund
25.98%
Hedge Fund
2.79%
Pension Fund
1.77%
Research Firm
1.69%
Sovereign Wealth Fund
1.18%
Bank and Trust
1.07%
Individual Investor
0.30%
Family Office
0.05%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
1177
117.06M
100.85%
-8.83M
2025Q2
1199
113.79M
98.03%
-7.04M
2025Q1
1255
117.73M
99.83%
-3.82M
2024Q4
1277
114.54M
95.28%
-3.97M
2024Q3
1253
112.35M
91.11%
-5.77M
2024Q2
1249
112.44M
91.13%
-1.63M
2024Q1
1287
107.57M
87.09%
-8.24M
2023Q4
1315
109.29M
88.55%
-2.41M
2023Q3
1347
106.10M
85.47%
-6.10M
2023Q2
1383
106.88M
85.21%
-9.65M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
T. Rowe Price Investment Management, Inc.
22.64M
19.51%
+126.19K
+0.56%
Jun 30, 2025
The Vanguard Group, Inc.
14.03M
12.09%
-297.65K
-2.08%
Jun 30, 2025
EdgePoint Investment Group Inc.
6.79M
5.85%
+1.43M
+26.65%
Jun 30, 2025
T. Rowe Price Associates, Inc.
7.80M
6.72%
-1.59M
-16.90%
Jun 30, 2025
Janus Henderson Investors
7.22M
6.22%
+1.23M
+20.47%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
5.81M
5%
-259.62K
-4.28%
Jun 30, 2025
State Street Investment Management (US)
5.02M
4.32%
-150.58K
-2.91%
Jun 30, 2025
Geode Capital Management, L.L.C.
2.98M
2.56%
-18.52K
-0.62%
Jun 30, 2025
Invesco Capital Management LLC
1.94M
1.67%
+422.41K
+27.88%
Jun 30, 2025
UBS Financial Services, Inc.
1.75M
1.51%
+1.12M
+178.25%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
First Trust Indxx Medical Devices ETF
2.12%
Invesco S&P 500 Equal Weight Health Care ETF
1.85%
T Rowe Price Capital Appreciation Equity ETF
1.36%
Simplify Health Care ETF
1.29%
ROBO Global Healthcare Technology & Innovation ETF
1.16%
First Trust Health Care Alphadex Fund
0.93%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.84%
VanEck Morningstar SMID Moat ETF
0.64%
Neuberger Berman Small-Mid Cap ETF
0.56%
NYLI Candriam US Mid Cap Equity ETF
0.5%
View more
First Trust Indxx Medical Devices ETF
Proportion2.12%
Invesco S&P 500 Equal Weight Health Care ETF
Proportion1.85%
T Rowe Price Capital Appreciation Equity ETF
Proportion1.36%
Simplify Health Care ETF
Proportion1.29%
ROBO Global Healthcare Technology & Innovation ETF
Proportion1.16%
First Trust Health Care Alphadex Fund
Proportion0.93%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
Proportion0.84%
VanEck Morningstar SMID Moat ETF
Proportion0.64%
Neuberger Berman Small-Mid Cap ETF
Proportion0.56%
NYLI Candriam US Mid Cap Equity ETF
Proportion0.5%
Dividend
A total of
168.35M
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
Oct 23, 2025
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 06, 2026 going ex on Jan 16, 2026
Jan 16, 2026
Feb 06, 2026
Jan 16, 2026
Jul 24, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Nov 07, 2025 going ex on Oct 17, 2025
Oct 17, 2025
Nov 07, 2025
Oct 17, 2025
Apr 24, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 08, 2025 going ex on Jul 18, 2025
Jul 18, 2025
Aug 08, 2025
Jul 18, 2025
Jan 23, 2025
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 09, 2025 going ex on Apr 17, 2025
Apr 18, 2025
May 09, 2025
Apr 17, 2025
Oct 24, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Feb 07, 2025 going ex on Jan 17, 2025
Jan 17, 2025
Feb 07, 2025
Jan 17, 2025
Jul 25, 2024
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 08, 2024 going ex on Oct 18, 2024
Oct 18, 2024
Nov 08, 2024
Oct 18, 2024
Apr 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Aug 09, 2024 going ex on Jul 19, 2024
Jul 19, 2024
Aug 09, 2024
Jul 19, 2024
Jan 25, 2024
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on May 10, 2024 going ex on Apr 18, 2024
Apr 19, 2024
May 10, 2024
Apr 18, 2024
Oct 26, 2023
RVTY.NB Interim Cash Dividend of gross USD 0.07 paid on Feb 09, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Feb 09, 2024
Jan 18, 2024
Jul 21, 2023
RVTY.NB Final Cash Dividend of gross USD 0.07 paid on Nov 10, 2023 going ex on Oct 19, 2023
Oct 20, 2023
Nov 10, 2023
Oct 19, 2023
View more
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Revvity Inc?
The top five shareholders of Revvity Inc are:
T. Rowe Price Investment Management, Inc. holds 22.64M shares, accounting for 19.51% of the total shares.
The Vanguard Group, Inc. holds 14.03M shares, accounting for 12.09% of the total shares.
EdgePoint Investment Group Inc. holds 6.79M shares, accounting for 5.85% of the total shares.
T. Rowe Price Associates, Inc. holds 7.80M shares, accounting for 6.72% of the total shares.
Janus Henderson Investors holds 7.22M shares, accounting for 6.22% of the total shares.
T. Rowe Price Investment Management, Inc. holds 22.64M shares, accounting for 19.51% of the total shares.
The Vanguard Group, Inc. holds 14.03M shares, accounting for 12.09% of the total shares.
EdgePoint Investment Group Inc. holds 6.79M shares, accounting for 5.85% of the total shares.
T. Rowe Price Associates, Inc. holds 7.80M shares, accounting for 6.72% of the total shares.
Janus Henderson Investors holds 7.22M shares, accounting for 6.22% of the total shares.
What are the top three shareholder types of Revvity Inc?
The top three shareholder types of Revvity Inc are:
T. Rowe Price Investment Management, Inc.
The Vanguard Group, Inc.
EdgePoint Investment Group Inc.
T. Rowe Price Investment Management, Inc.
The Vanguard Group, Inc.
EdgePoint Investment Group Inc.
How many institutions hold shares of Revvity Inc (RVTY)?
As of 2025Q3, 1177 institutions hold shares of Revvity Inc, with a combined market value of approximately 117.06M, accounting for 100.85% of the total shares. Compared to 2025Q2, institutional shareholding has increased by 2.82%.
What is the biggest source of revenue for Revvity Inc?
In FY2025Q2, the Product business generated the highest revenue for Revvity Inc, amounting to 610.70M and accounting for 84.79% of total revenue.
